Dermatology NewsInvestigational lupus drug cenerimod moves to phase 3 studies after equivocal phase 2 resultsMay 26, 2023Autoimmune Diseases
Dermatology NewsSevere hydroxychloroquine nonadherence linked to worse SLE outcomesMay 25, 2023Autoimmune Diseases
Dermatology NewsLupus landmark study aims for personalized medicine goalsMay 24, 2023Autoimmune Diseases
Dermatology NewsCutaneous vasculitis curtails quality of lifeMay 11, 2023Rare DiseasesAutoimmune Diseases
Dermatology NewsIVIG shows no impact on VTE risk in dermatomyositis patientsMay 11, 2023Autoimmune DiseasesRare Diseases
Dermatology NewsFDA fast tracks potential CAR T-cell therapy for lupusMay 3, 2023Autoimmune DiseasesHealth Policy
Dermatology NewsChildhood lupus severity linked to social determinants of healthApril 4, 2023PediatricsRare DiseasesAutoimmune Diseases
Dermatology NewsNew coalition aims to revolutionize stalled lupus researchMarch 30, 2023Autoimmune Diseases
Dermatology NewsBiosimilars and patients: Discussions should address safety, cost, and anxiety about changeMarch 30, 2023Business of MedicinePsoriatic ArthritisPediatricsRare DiseasesPsoriasisAutoimmune Diseases
Dermatology NewsAnifrolumab shows promise in refractory discoid lupus erythematosusMarch 27, 2023Autoimmune DiseasesMedical Dermatology
Dermatology NewsCT results in myositis inform cancer screening strategiesMarch 24, 2023Autoimmune DiseasesRare Diseases
Dermatology NewsNovel therapy shows promise for treating skin-predominant dermatomyositisMarch 21, 2023Autoimmune DiseasesMedical Dermatology
Dermatology NewsExperts share real-world experience prescribing voclosporin, belimumab for lupus nephritisMarch 8, 2023Autoimmune Diseases
Dermatology NewsAutoantibodies signal reduced cancer risk in dermatomyositisFebruary 22, 2023Autoimmune DiseasesRare Diseases
